Incyte's povorcitinib shows strong 24-week STOP-HS data in hidradenitis suppurativa, supporting 2025-2026 regulatory filings.

Some of Sanofi’s most high-profile readouts this year can’t have made for easy reading at the French pharma’s Paris ...

Incyte (INCY) announced new 24-week interim data evaluating the safety and efficacy of povorcitinib, an oral small-molecule highly-selective JAK1 ...

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa ...

A Hartlepool vets practice has had 10 seals brought to the surgery, either dead, or needing to be put to sleep ...

Thousands of much-needed dental appointments have been made available for people in Birmingham and Solihull who are desperate ...

In a recent study, Dr. Claudine Abegg and her colleagues analyzed the remains of a mummified cranium housed in the ...

Thousands of extra urgent dental appointments are now available for people living in the Black Country who need urgent dental care.

If you regularly wake with a dry mouth, it is important to tackle hydrating it to reduce risk of further oral diseases. Dr ...

Andrew Oakes told Newsweek he wanted to die after the diagnosis because it was like a dirty secret and people called him reckless.